These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
284 related articles for article (PubMed ID: 31355524)
1. The establishment of immune infiltration based novel recurrence predicting nomogram in prostate cancer. Meng J; Liu Y; Guan S; Fan S; Zhou J; Zhang M; Liang C Cancer Med; 2019 Sep; 8(11):5202-5213. PubMed ID: 31355524 [TBL] [Abstract][Full Text] [Related]
2. A model based on tumor-infiltrating immune cells for predicting the relapse rates of patients with testicular germ cell tumors. Wang Y; Ji C; Liu J; Wang Y; Song N; Cao P Int Immunopharmacol; 2020 Sep; 86():106710. PubMed ID: 32652500 [TBL] [Abstract][Full Text] [Related]
3. Identification of recurrence marker associated with immune infiltration in prostate cancer with radical resection and build prognostic nomogram. Rui X; Shao S; Wang L; Leng J BMC Cancer; 2019 Dec; 19(1):1179. PubMed ID: 31795990 [TBL] [Abstract][Full Text] [Related]
4. Comprehensive Analysis of Tumor-Infiltrating Immune Cells and Relevant Therapeutic Strategy in Esophageal Cancer. Lu G; Chen L; Wu S; Feng Y; Lin T Dis Markers; 2020; 2020():8974793. PubMed ID: 32454908 [TBL] [Abstract][Full Text] [Related]
5. Exploration of the Tumor Mutational Burden as a Prognostic Biomarker and Related Hub Gene Identification in Prostate Cancer. Wang L; Yao Y; Xu C; Wang X; Wu D; Hong Z Technol Cancer Res Treat; 2021; 20():15330338211052154. PubMed ID: 34806485 [TBL] [Abstract][Full Text] [Related]
6. A gene expression-based study on immune cell subtypes and glioma prognosis. Zhong QY; Fan EX; Feng GY; Chen QY; Gou XX; Yue GJ; Zhang GH BMC Cancer; 2019 Nov; 19(1):1116. PubMed ID: 31729963 [TBL] [Abstract][Full Text] [Related]
7. Exploration of gene expression profiles and immune microenvironment between high and low tumor mutation burden groups in prostate cancer. Luo C; Chen J; Chen L Int Immunopharmacol; 2020 Sep; 86():106709. PubMed ID: 32593155 [TBL] [Abstract][Full Text] [Related]
8. Immune cell analyses of the tumor microenvironment in prostate cancer highlight infiltrating regulatory T cells and macrophages as adverse prognostic factors. Andersen LB; Nørgaard M; Rasmussen M; Fredsøe J; Borre M; Ulhøi BP; Sørensen KD J Pathol; 2021 Oct; 255(2):155-165. PubMed ID: 34255349 [TBL] [Abstract][Full Text] [Related]
9. Identification of a Novel Nomogram to Predict Progression Based on the Circadian Clock and Insights Into the Tumor Immune Microenvironment in Prostate Cancer. Feng D; Xiong Q; Zhang F; Shi X; Xu H; Wei W; Ai J; Yang L Front Immunol; 2022; 13():777724. PubMed ID: 35154101 [TBL] [Abstract][Full Text] [Related]
10. Tumor-Infiltrating Immune Cells Act as a Marker for Prognosis in Colorectal Cancer. Ye L; Zhang T; Kang Z; Guo G; Sun Y; Lin K; Huang Q; Shi X; Ni Z; Ding N; Zhao KN; Chang W; Wang J; Lin F; Xue X Front Immunol; 2019; 10():2368. PubMed ID: 31681276 [TBL] [Abstract][Full Text] [Related]
11. Profiles of immune cell infiltration in head and neck squamous carcinoma. Liang B; Tao Y; Wang T Biosci Rep; 2020 Feb; 40(2):. PubMed ID: 32095823 [TBL] [Abstract][Full Text] [Related]
12. LAYN Is a Prognostic Biomarker and Correlated With Immune Infiltrates in Gastric and Colon Cancers. Pan JH; Zhou H; Cooper L; Huang JL; Zhu SB; Zhao XX; Ding H; Pan YL; Rong L Front Immunol; 2019; 10():6. PubMed ID: 30761122 [No Abstract] [Full Text] [Related]
13. Gene expression-based immune infiltration analyses of renal cancer and their associations with survival outcome. Chen L; Yin L; Qi Z; Li J; Wang X; Ma K; Liu X BMC Cancer; 2021 May; 21(1):595. PubMed ID: 34030645 [TBL] [Abstract][Full Text] [Related]
14. Profiles of immune cell infiltration and immune-related genes in the tumor microenvironment of osteosarcoma. Zhang C; Zheng JH; Lin ZH; Lv HY; Ye ZM; Chen YP; Zhang XY Aging (Albany NY); 2020 Feb; 12(4):3486-3501. PubMed ID: 32039832 [TBL] [Abstract][Full Text] [Related]
15. Tumor infiltrating M2 macrophages could predict biochemical recurrence of localized prostate cancer after radical prostatectomy. Zhang Q; Xia J; Wang Y; Zhang J; Ji C; Cong R; Wang Y; Song N Exp Cell Res; 2019 Nov; 384(1):111588. PubMed ID: 31473209 [TBL] [Abstract][Full Text] [Related]
16. Investigating the significance of tumor-infiltrating immune cells for the prognosis of lung squamous cell carcinoma. Zhu Y; Zhang X PeerJ; 2019; 7():e7918. PubMed ID: 31667016 [TBL] [Abstract][Full Text] [Related]
17. Significance of Tumor-Infiltrating Immune Cells in the Prognosis of Colon Cancer. Wu D; Ding Y; Wang T; Cui P; Huang L; Min Z; Xu M Onco Targets Ther; 2020; 13():4581-4589. PubMed ID: 32547088 [TBL] [Abstract][Full Text] [Related]
18. The prognostic value and potential mechanism of Matrix Metalloproteinases among Prostate Cancer. Geng X; Chen C; Huang Y; Hou J Int J Med Sci; 2020; 17(11):1550-1560. PubMed ID: 32669958 [No Abstract] [Full Text] [Related]
19. The Landscape of Immune Cells Infiltrating in Prostate Cancer. Wu Z; Chen H; Luo W; Zhang H; Li G; Zeng F; Deng F Front Oncol; 2020; 10():517637. PubMed ID: 33194581 [TBL] [Abstract][Full Text] [Related]
20. Prognostic Implications of Heterogeneity in Intra-tumoral Immune Composition for Recurrence in Early Stage Lung Cancer. Mony JT; Schuchert MJ Front Immunol; 2018; 9():2298. PubMed ID: 30374348 [No Abstract] [Full Text] [Related] [Next] [New Search]